NY Times article on Bio-Identical Hormone Replacement Therapy

[Guest guest]

Hi Health Activists,

Some degree of change is taking place. The New York Times Magazine Section

included a highly publicized article featuring the benefits of

Bio-identical hormone replacement therapy.

The article " The Estrogen Dilemma " by Cynthia Gorney in the NY Times

Magazine of April 18,2010 is available below:

_http://www.nytimes.com/2010/04/18/magazine/18estrogen-t.html?ref=todayspape

r_

(http://www.nytimes.com/2010/04/18/magazine/18estrogen-t.html?ref=todayspaper)

This has become increasingly important after the disastrous results of the

Women's Health Initiative (WHI) study of horse estrogen based hormone

replacement therapy(HRT), that had to be stopped in 2002 when it became apparent

that HRT using horse estrogens that had been promoted for the past 25

years had resulted in substantial increases in Heart Disease,stroke, blood

clots and breast cancer. In prior years women were told it would prevent

these, and the results were said to be " surprising. "

 

In truth Alternative Medical Doctors had been warning of these dangers for

years and had developed alternatives including Bio-identical hormones.

 

 

For details on Bio-Identical Hormones see Dr.Jonathan V Wright,MD websites:

_www.wrightnewsletter.com_ (http://www.wrightnewsletter.com)

_www.tahoma-clinic.com_ (http://www.tahoma-clinic.com)

 

The Times article mentions the benefits of Bio-Identical Hormones, but

does not mention that the Food & Drug Administration (FDA) is entertaining a

petition from Wyeth pharmaceuticals, the main manufacturer of patented

Horse Estrogen's that were implicated in all those dangerous conditions found

in the WHI to ban or severely restrict a doctors ability to prescribe

estriol (a form of estrogen) that is needed to formulate the most natural

combination of hormones necessary to implement Bio-Identical Hormone

Replacement

Therapy. FDA maintains that doctors can fill out the paperwork for a

Investigational New Drug (IND) if they want to prescribe estriol, which has a

very

good record of safety. This very extraordinary process, is something

doctors will not want to go through and be called to the attention of the FDA

and their state medical boards. It is nothing but intimidation. Please write

to the New York Times magazine section, asking that they complete the

information in the article about how a patient's right to have access to

bio-identical hormone replacemrnt therapy is being threatened by the FDA and

Wyeth

pharmaceuticals request to restrict access to this drug.

 

To contact the NY Times Magazine send an Email to: _magazine_

(magazine)

All letters should have your name, address and daytime telephone number.

You can also send an email to your congressional representative and US

Senators. Asking that they make sure the FDA does not limit your access to

bio identical hormones, particularly estriol (a form of estrogen) that Wyeth

pharmaceuticals has asked the FDA to prohibit, despite its safety record and

effectiveness.

Arnold

Arnold